Susan F. Laska
FDA investigator
Appears on 3 documents from 2004, mostly at sites in Pennsylvania. Most often cites reserve samples (21 CFR 211.170).
- 3
- Documents on file
- 14.0
- Observations per 483
- 2004
- First seen
- 2004
- Most recent
What they cite most
From 14 observations- 21 CFR 211.170Reserve samples2
- 21 CFR 211.192Production record review2
- 21 CFR 211.115Reprocessing1
- 21 CFR 211.122Materials examination and usage criteria1
- 21 CFR 211.125Labeling issuance1
- 21 CFR 211.160General requirements1
Activity by year
2004: 3
Where
Pennsylvania 3
Often inspects with
Jacqueline A. Oshaughnessy· Martin K. Yau· Michael F. Skelly
Is Susan F. Laska coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2004-12-21 | fda_correspondence MDS Pharma ServicesDec 21, 2004 · King of Prussia, Pennsylvania | King of Prussia, Pennsylvania | — | |
| 2004-06-07 | 483 McNeil Consumer HealthcareJun 7, 2004 · Fort Washington, Pennsylvania | Fort Washington, Pennsylvania | 14 | |
| 2004-06-07 | EIR McNeil Consumer & Specialty Pharmaceuticals, Division of McNeil-PPC, Inc.Jun 7, 2004 · Fort Washington, Pennsylvania | Fort Washington, Pennsylvania | — |
About this profile
What does Susan F. Laska inspect?
Susan F. Laska appears on 3 documents on file covering 1 site, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.170 (reserve samples), followed by 21 CFR 211.192 and 21 CFR 211.115.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Susan F. Laska is dated Dec 21, 2004.